No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
LFST240719P8000
- 2.48
- +0.83+50.30%
15min DelayClose Jul 19 15:59 ET
2.48High2.41Low
2.41Open1.65Pre Close2 Volume47 Open Interest8.00Strike Price489.00Turnover0.00%IV-0.36%PremiumJul 19, 2024Expiry Date2.50Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.22Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024
SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings
LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Could Be 39% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for LifeStance Health Group is US$8.70 based on 2 Stage Free Cash Flow to Equity Current share price of US$5.33 suggests LifeStance Health Group is
Peering Into LifeStance Health Gr's Recent Short Interest
LifeStance Health Gr's (NYSE:LFST) short percent of float has fallen 5.99% since its last report. The company recently reported that it has 16.01 million shares sold short, which is 20.1% of all
Wall Street Analysts See a 57.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
LifeStance Health Group Finalizes Executive Separation Terms
Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
As the 19th Benzinga Cannabis Capital Conference, returns (Oct. 8-9) in Chicago, gathering top CEOs, investors, and leaders in the cannabis industry, let's scroll through the latest leadership changes
Comments
LifeStance Health Group's positive outlook appears to be priced in, but its high growth potential at a fair price makes it an attractive investment. Higher cash flow is expected, potentially leading to a higher share valuation.
Is LifeStance Health Group, Inc. (NASDAQ:LFST) Potentially Undervalued? 1
LifeStance's CEO, Ken Burdick, is confident that Dr. DeLuca's skills will complement the board as they expand mental healthcare access. Dr. DeLuca is excited to join and help more patients receive personalized care.
1
LifeStance Health Group's high P/S ratio reflects market expectations of continued strong revenue growth. Investors may overpay if these expectations aren't met, but strong future revenue forecasts suggest a decrease in revenues is unlikely.
Despite top line growth, LifeStance Health Group is incurring a loss of US$145m on the EBIT line. The company's balance sheet, burdened with liabilities against cash, is deemed unfit and risky.
1
CEO Ken Burdick is confident in Dr. Ramtekkar's ability to drive exceptional patient and clinical outcomes, citing his commitment to clinical excellence. Dr. Ramtekkar is excited to join LifeStance and continue setting the bar for clinical excellence in mental health.
1
Read more